Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
77
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. ArriVent BioPharma Inc. market cap is $544.13M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. ArriVent BioPharma Inc. 52 week high is $35.83 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ArriVent BioPharma Inc. 52 week low is $10.33 as of November 22, 2026.
ArriVent BioPharma Inc. stock price today is $10.52.
ArriVent BioPharma Inc. stock price yesterday was $11.26.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. ArriVent BioPharma Inc.'s P/E ratio is -2.87.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. ArriVent BioPharma Inc. P/B ratio is 1.3692.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. ArriVent BioPharma Inc. 50-day moving average is $19.48.